Clinically-validated Tru-D SmartUVC to Exhibit at 2018 HealthTrust University Conference

NASHVILLE, Tenn., July 16, 2018 /PRNewswire/ -- A leader in the UVC disinfection industry, Tru-D SmartUVC, will join members of HealthTrust at the organization's upcoming University Conference & Vendor Fair in Nashville, Tennessee, July 23-25 in booth #662. Validated by more than 15 independent studies on UVC disinfection, Tru-D invites members to learn how its innovative technology implements seamlessly into hospitals' infection prevention programs and workflow, making the entire facility cleaner and safer for patients and staff.

Tru-D has been a contracted HealthTrust supplier since January 1, 2015, working with supply chain management professionals to help save hospitals precious dollars and improve patient outcomes. HealthTrust, which serves more than 1,600 hospitals and members in more than 22,600 site locations, is one of the industry's only truly committed and aligned group purchasing models.

The only UVC device validated by a randomized clinical trial, Tru-D has been proven to not only decrease the risk of acquisition and infection for the next patient who enters a room, but also throughout the entire facility, positively affecting outcomes for all patients. Following the two-year, $2M, CDC-funded Benefits of Enhanced Terminal Room-Disinfection (BETR-Disinfection) study, the researchers concluded that, "Enhanced terminal room disinfection with UV in a targeted subset of high-risk rooms led to a decrease in hospital-wide incidence of C. difficile and VRE."

"Only Tru-D has been proven to provide a safer environment for everyone who enters a hospital's doors," said Alice Brewer, MPH, CIC, Director of Clinical Affairs for Tru-D SmartUVC. "We look forward to sharing a new analysis from the BETR-Disinfection study with attendees of HealthTrust's University Conference."

Operating at the optimal wavelength for germicidal disinfection, Tru-D kills up to 99.9% of pathogens in both direct and shadowed areas. Through its patented Sensor360 technology, Tru-D is able to provide thorough disinfection from one placement in the room, eliminating human error as well as the need for additional full-time employees for operation. Tru-D pioneered the UVC disinfection industry, placing the first robot in a health care facility in 2007. Through its programmatic approach to standardizing UVC implementation and utilization in hospitals as well as its dedication to innovation and customer experiences, Tru-D is on a mission to eradicate hospital-acquired infections.

For more information and links to independent studies, visit Tru-D.com.

About Tru-D SmartUVC

Only Tru-D delivers an automated, measured dose of UVC light to consistently disinfect a room during one cycle. Operating from one placement in the room, Tru-D ensures significant pathogen reduction in direct and shadowed areas. Validated by more than a dozen independent studies as well as a well-controlled, large-scale, CDC-funded randomized clinical trial, Tru-D's automated, measured dosing capabilities and real-time usage-tracking features make it one of the most advanced UV disinfection systems available. To learn more, visit tru-d.com.

MEDIA RELEASE      
Christin Yates
Tru-D Public Relations
901-774-5771
[email protected]

SOURCE Tru-D SmartUVC